Clinical Trials Arena November 25, 2024
The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light on what sustainability leaders are doing well, and points to areas where those that have fallen behind can improve.
Recent research from GlobalData analyzed the Net Zero strategies of the world’s top 18 pharmaceutical companies by revenue. All of them — including giants like Pfizer, AstraZeneca, and Johnson & Johnson — have committed to the green transition, particularly through the reduction of Scope 1 and 2 emissions arising from direct operations and the use of electricity. Between 2019 and 2022, 17 out of the 18 companies were successful in doing so, with total combined emissions dropping from approximately 14 million...
Today's Sponsors
Today's Sponsor